This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated IL12RB1 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-IL12RB1 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~73.1 kDa | |
| Observed band | ~70 kDa | |
| Gel | 10–12% | |
| Negative control | siRNA / KO lysate |
| PTM | Glycosylated + Cleaved | |
| Caveat | Heavy N-glycosylation | |
| Regulation | IL-6 up | |
| Isoform | 3 isoform(s) |
Literature-validated Western blot parameters for IL12RB1 — gel percentage, transfer, blocking, antibody incubation and detection, extracted from published methods.
| Sample / lysate | HEPG2 . After Electrophoresis, proteins were transferred to a Nitrocellulose membrane at 150mA for 50-90 minutes. Blocked the membrane with 5% Non-fat Milk/ TBS for 1.5 hour at RT. The membrane was incubated with rabbit anti-IL12RB1 antigen affinity purified polyclonal antibody (Catalog # A03401-1) at 0.5 μg/mL overnight at 4°C, then washed with TBS-0.1%Tween 3 times with 5 minutes each and probed with a goat anti-rabbit IgG-HRP secondary antibody at a dilution of 1:10000 for 1.5 hour at RT. The signal is developed using an Enhanced Chemiluminescent detection (ECL) kit (Catalog # EK1002) with Tanon 5200 system. A specific band was detected for IL12RB1 at approximately 70KD. The expected band size for IL12RB1 is at 73KD |
| Gel % | 10–12% |
| Load | 50ug |
| Transfer | nitrocellulose membrane, 150 mA, 50–90 min |
| Membrane | nitrocellulose |
| Blocking | 5% non-fat milk / TBS, 1.5 h RT |
| Primary antibody | 0.5 µg/mL |
| Primary incubation | overnight at 4 °C |
| Secondary antibody | goat anti-rabbit IgG-HRP, 1:10000 |
| Wash | TBS-0.1% Tween, 3 × 5 min |
| Detection | ECL |
| Exposure / imaging | Tanon 5200 |
| Observed band | 70 kDa |
IL12RB1 has a 73.1 kDa predicted mass but is typically observed at ~70 kDa by Western blot, reflecting signal-peptide cleavage and glycosylation at up to six N-linked sites.
| Single band at approximately 70 kDa on reducing SDS-PAGE | corresponds to the mature, signal-peptide-cleaved IL12RB1 chain running close to its 73.1 kDa calculated mass |
| Band is diffuse or slightly broadened rather than a crisp line | reflects heterogeneous occupancy across the 6 N-linked glycosylation sites on the extracellular domain |
| Apparent size falls a little below the 73.1 kDa full-length calculated mass | removal of the 23-residue N-terminal signal peptide during maturation trims mass from the precursor |
| More than one distinct band at different apparent sizes | IL12RB1 has 3 annotated splice isoforms that can be co-expressed and differ in length |
| Little or no band in a cytosol-only or poorly solubilized lysate | IL12RB1 is a single-pass type I membrane receptor and requires adequate membrane solubilization to be extracted, not a soluble/cytosolic protein |
| Slight mobility shift between reduced and non-reduced samples | an intrachain disulfide bond (Cys52-Cys62) stabilizes a folded extracellular subdomain that migrates differently depending on reduction |
| Predicted mass from UniProt (73.1 kDa, 662 aa) | sets the calculated baseline against which the ~70 kDa observed band is compared |
| N-terminal signal peptide (residues 1-23) | cleaved during maturation, so the mature membrane-bound receptor runs somewhat below the calculated precursor mass |
| N-linked glycosylation (6 sites, including Asn121, Asn329, Asn346, Asn352, Asn442, Asn456) | adds variable mass and can broaden or shift the band depending on glycoform heterogeneity across cell types |
| Intrachain disulfide bond (Cys52-Cys62) | stabilizes domain folding and can cause a modest mobility shift between fully reduced and non-reduced samples |
| Three splice isoforms (1, 2, 3) | can generate additional bands of different apparent size if more than one isoform is expressed in the sample |
| Situation | Likely cause | Next action |
|---|---|---|
| Weak or no signal | IL12RB1 is a receptor restricted mainly to activated T, NK, and myeloid cells, so many general cell lines express little of it | use lysate from IL12RB1-expressing cells such as activated PBMCs or NK cells and load sufficient membrane protein, as in the ~50 ug used for the reference blot |
| No band in lysate | the single-pass transmembrane protein was not solubilized because lysis buffer lacked adequate detergent or lysate captured cytosol only | use a lysis buffer with sufficient detergent (e.g. RIPA or NP-40 based) to solubilize the membrane fraction before loading |
| Broad smear instead of sharp band | heterogeneous occupancy and processing across the 6 N-linked glycosylation sites produces glycoform microheterogeneity | treat a parallel sample with PNGase F to collapse the smear toward a sharper core polypeptide band for confirmation |
| Multiple bands | co-expression of the 3 annotated splice isoforms, or a mix of glycosylation intermediates, can appear as separate bands | treat the ~70 kDa band as the primary mature product and check antibody epitope coverage against isoform sequences |
| Band lower than expected | signal peptide cleavage during maturation or partial degradation/deglycosylation reduces apparent mass below the 73.1 kDa precursor value | compare against the ~70 kDa reference band and use fresh lysate with protease inhibitors to rule out degradation |
| Fragments below expected size | proteolytic clipping of the extracellular domain during cell lysis or sample handling | prepare lysate fresh with protease inhibitors and minimize freeze-thaw cycles before loading |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|
| Tissue | Cell type | Level | Evidence | Source |
|---|
Deeper troubleshooting and optimisation questions for IL12RB1, answered from its protein features.
BosterBio's IL12RB1 antibodies are among the best-performing WB antibodies on the market — well cited, thoroughly validated, and orthogonally cross-validated against negative tissues and complementary methods.
Our recommended anti-IL12RB1 antibody is a best-performing, extensively cited reagent for Western blot, rigorously validated through orthogonal approaches including negative-tissue controls and complementary detection methods, giving researchers high confidence in specific, reproducible detection of IL12RB1 across sample types.
Which to pick: Only one Boster antibody is catalogued for IL12RB1, A03401-1, which includes a validated Western blot image demonstrating specific detection—making it the clear, single choice for your IL12RB1 Western blot experiments; no alternative SKUs are currently available to compare.